Amicus Therapeutics, Inc.
Loading chart...
Loading financial statements...
Financial statements
data from SEC XBRL filings. Values are as-reported; restatements supersede originals. Values reported in .
| Line item |
|---|
| Period ending |
Next expected filings
- ~2026-11-04 10-Q expected by 2026-11-06 (in 52 days)
- ~2027-02-19 10-K expected by 2027-02-22 (in 159 days)
- ~2027-05-01 10-Q expected by 2027-05-03 (in 230 days)
- ~2027-07-31 10-Q expected by 2027-08-02 (in 321 days)
Predicted from historical filing cadence; not an SEC commitment.
Recent SEC filings
- 2026-04-27 8-K Material Agreement Terminated; Completion of Acquisition/Disposition; Delisting Notice; Material Modification to Rights; Control Change; Officer/Director Change; Bylaws/Articles Amended; Financial Statements and Exhibits
- 2026-04-23 8-K Other Events
- 2026-02-20 10-K Annual Report
- 2026-02-20 8-K Earnings Release; Financial Statements and Exhibits
- 2026-01-26 8-K Earnings Release; Regulation FD Disclosure
- 2025-12-19 8-K Material Agreement Entered; Bylaws/Articles Amended; Regulation FD Disclosure; Financial Statements and Exhibits
- 2025-11-04 10-Q Quarterly Report
- 2025-11-04 8-K Earnings Release; Financial Statements and Exhibits
- 2025-07-31 10-Q Quarterly Report
- 2025-07-31 8-K Earnings Release; Financial Statements and Exhibits
- 2025-05-01 10-Q Quarterly Report
- 2025-05-01 8-K Earnings Release; Financial Statements and Exhibits
- 2025-05-01 8-K Material Agreement Entered; Regulation FD Disclosure; Financial Statements and Exhibits
- 2025-02-19 10-K Annual Report
- 2025-02-19 8-K Earnings Release; Financial Statements and Exhibits